# Eagle Bancorp Inc: financial statements, quarterly

EGBN · Nasdaq · CIK 1050441 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/egbn.md) · [Financials](/companies/egbn/financials.md) · [Filings](/companies/egbn/filings.md) · [Insiders](/companies/egbn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/egbn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [90.4](/filings/0001050441-23-000147.md) | [94.4 d](/filings/0001050441-24-000053.md) | [101](/filings/0001050441-24-000079.md) | [98.4](/filings/0001050441-24-000117.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [7.2](/filings/0001050441-24-000152.md) | [4.7 d](/filings/0001050441-26-000021.md) | [3.0](/filings/0001050441-25-000088.md) | [4.4](/filings/0001050441-25-000108.md) | [4.9](/filings/0001050441-25-000134.md) | [4.5 d](/filings/0001050441-26-000021.md) | [0.8](/filings/0001050441-26-000066.md) | [(39.4)](/filings/0001050441-26-000096.md) | [(16.9)](/filings/0001050441-25-000134.md) | [(2.6) d](/filings/0001050441-26-000021.md) | [1.3](/filings/0001050441-26-000066.md) | [0.7](/filings/0001050441-26-000096.md) |
| Net income | $m | [27.4](/filings/0001050441-24-000152.md) | [20.2 d](/filings/0001050441-26-000021.md) | [(0.3)](/filings/0001050441-25-000088.md) | [(83.8)](/filings/0001050441-25-000108.md) | [21.8](/filings/0001050441-25-000134.md) | [15.3 d](/filings/0001050441-26-000021.md) | [1.7](/filings/0001050441-26-000066.md) | [(69.8)](/filings/0001050441-26-000096.md) | [(67.5)](/filings/0001050441-25-000134.md) | [(2.4) d](/filings/0001050441-26-000021.md) | [14.7](/filings/0001050441-26-000066.md) | [6.9](/filings/0001050441-26-000096.md) |
| Diluted EPS | $ per share | [0.91](/filings/0001050441-24-000152.md) | not reported | [(0.01)](/filings/0001050441-25-000088.md) | [(2.78)](/filings/0001050441-25-000108.md) | [0.72](/filings/0001050441-25-000134.md) | not reported | [0.06](/filings/0001050441-26-000066.md) | [(2.30)](/filings/0001050441-26-000096.md) | [(2.22)](/filings/0001050441-25-000134.md) | not reported | [0.48](/filings/0001050441-26-000066.md) | [0.23](/filings/0001050441-26-000096.md) |
| Basic EPS | $ per share | [0.91](/filings/0001050441-24-000152.md) | not reported | [(0.01)](/filings/0001050441-25-000088.md) | [(2.78)](/filings/0001050441-25-000108.md) | [0.72](/filings/0001050441-25-000134.md) | not reported | [0.06](/filings/0001050441-26-000066.md) | [(2.30)](/filings/0001050441-26-000096.md) | [(2.22)](/filings/0001050441-25-000134.md) | not reported | [0.48](/filings/0001050441-26-000066.md) | [0.23](/filings/0001050441-26-000096.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [11.2](/filings/0001050441-23-000147.md) | [11.7](/filings/0001050441-25-000051.md) | [11.6](/filings/0001050441-24-000079.md) | [11.3](/filings/0001050441-24-000117.md) | [11.3](/filings/0001050441-24-000152.md) | [11.1](/filings/0001050441-26-000021.md) | [11.3](/filings/0001050441-25-000088.md) | [10.6](/filings/0001050441-25-000108.md) | [10.8](/filings/0001050441-25-000134.md) | [10.5](/filings/0001050441-26-000096.md) | [10.0](/filings/0001050441-26-000066.md) | [9.7](/filings/0001050441-26-000096.md) |
| Total liabilities | $bn | [9.9](/filings/0001050441-23-000147.md) | [10.4](/filings/0001050441-25-000051.md) | [10.4](/filings/0001050441-24-000079.md) | [10.1](/filings/0001050441-24-000117.md) | [10.1](/filings/0001050441-24-000152.md) | [9.9](/filings/0001050441-26-000021.md) | [10.1](/filings/0001050441-25-000088.md) | [9.4](/filings/0001050441-25-000108.md) | [9.7](/filings/0001050441-25-000134.md) | [9.4](/filings/0001050441-26-000096.md) | [8.8](/filings/0001050441-26-000066.md) | [8.5](/filings/0001050441-26-000096.md) |
| Long-term debt | $bn | [0.1](/filings/0001050441-23-000147.md) | [0.0](/filings/0001050441-25-000051.md) | not reported | not reported | [0.1](/filings/0001050441-24-000152.md) | [0.1](/filings/0001050441-26-000021.md) | [0.1](/filings/0001050441-25-000088.md) | [0.1](/filings/0001050441-25-000108.md) | [0.1](/filings/0001050441-25-000134.md) | [0.1](/filings/0001050441-26-000096.md) | [0.1](/filings/0001050441-26-000066.md) | [0.1](/filings/0001050441-26-000096.md) |
| Short-term borrowings | $bn | not reported | [1.4](/filings/0001050441-25-000051.md) | not reported | not reported | [1.2](/filings/0001050441-24-000152.md) | [0.5](/filings/0001050441-26-000021.md) | [0.5](/filings/0001050441-25-000088.md) | [0.1](/filings/0001050441-25-000108.md) | [0.0](/filings/0001050441-25-000134.md) | [0.0](/filings/0001050441-26-000096.md) | [0.0](/filings/0001050441-26-000066.md) | not reported |
| Shareholders' equity | $bn | [1.2](/filings/0001050441-24-000152.md) | [1.3](/filings/0001050441-26-000021.md) | [1.3](/filings/0001050441-25-000108.md) | [1.2](/filings/0001050441-25-000134.md) | [1.2](/filings/0001050441-25-000134.md) | [1.2](/filings/0001050441-26-000096.md) | [1.2](/filings/0001050441-26-000096.md) | [1.2](/filings/0001050441-26-000096.md) | [1.1](/filings/0001050441-25-000134.md) | [1.1](/filings/0001050441-26-000096.md) | [1.1](/filings/0001050441-26-000096.md) | [1.2](/filings/0001050441-26-000096.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [47.4 d](/filings/0001050441-24-000152.md) | [56.7 d](/filings/0001050441-26-000021.md) | [2.8](/filings/0001050441-25-000088.md) | [55.2 d](/filings/0001050441-25-000108.md) | [55.6 d](/filings/0001050441-25-000134.md) | [10.1 d](/filings/0001050441-26-000021.md) | [43.2](/filings/0001050441-26-000066.md) | [(28.6) d](/filings/0001050441-26-000096.md) | [19.8 d](/filings/0001050441-25-000134.md) | [(5.9) d](/filings/0001050441-26-000021.md) | [14.9](/filings/0001050441-26-000066.md) | [32.4 d](/filings/0001050441-26-000096.md) |
| Capital expenditure | $m | not reported | not reported | [0.1](/filings/0001050441-25-000088.md) | [(0.0) d](/filings/0001050441-25-000108.md) | [0.2 d](/filings/0001050441-25-000134.md) | [0.1 d](/filings/0001050441-26-000021.md) | [0.1](/filings/0001050441-26-000066.md) | [0.7 d](/filings/0001050441-26-000096.md) | [4.0 d](/filings/0001050441-25-000134.md) | [2.9 d](/filings/0001050441-26-000021.md) | [0.6](/filings/0001050441-26-000066.md) | [0.9 d](/filings/0001050441-26-000096.md) |
| Dividends paid | $m | [13.5 d](/filings/0001050441-24-000152.md) | [14.2 d](/filings/0001050441-26-000021.md) | [13.5](/filings/0001050441-25-000088.md) | [13.6 d](/filings/0001050441-25-000108.md) | [13.6 d](/filings/0001050441-25-000134.md) | [5.0 d](/filings/0001050441-26-000021.md) | [5.0](/filings/0001050441-26-000066.md) | [5.0 d](/filings/0001050441-26-000096.md) | [5.0 d](/filings/0001050441-25-000134.md) | [0.3 d](/filings/0001050441-26-000021.md) | [0.3](/filings/0001050441-26-000066.md) | [0.3 d](/filings/0001050441-26-000096.md) |
| Share repurchases | $m | [(0.0) d](/filings/0001050441-24-000152.md) | [(0.0) d](/filings/0001050441-26-000021.md) | [0.0](/filings/0001050441-24-000079.md) | [0.0 d](/filings/0001050441-24-000117.md) | [0.0 d](/filings/0001050441-24-000152.md) | [0.0 d](/filings/0001050441-26-000021.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [32.2](/filings/0001050441-23-000147.md) | [31.2](/filings/0001050441-24-000079.md) | [30.5](/filings/0001050441-24-000117.md) | [29.9](/filings/0001050441-24-000152.md) | [30.1](/filings/0001050441-25-000088.md) | [30.2](/filings/0001050441-25-000108.md) | [30.2](/filings/0001050441-25-000134.md) | [30.4](/filings/0001050441-26-000066.md) | [30.4](/filings/0001050441-26-000096.md) | [30.4](/filings/0001050441-25-000134.md) | [30.5](/filings/0001050441-26-000066.md) | [30.6](/filings/0001050441-26-000096.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 30,483,973 at 2026-08-01, from the cover of the [10-Q filed 2026-08-06](/filings/0001050441-26-000096.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.